Short-term Clinical:
Asthma, Diabetes, Hypertension
- Pre-post controlled (1 yr pre and 1 yr post)
- Improvements in processes of care for asthma and diabetes
- Asthma—Rx anti-inflam med 14%
- Diabetes—HbA1c measurement 16%
- No improvement in intermediary outcomes
Landon et al. NEJM 2007; 356:921-934.
Previous Slide Contents Next Slide ![Next Slide](https://webarchive.library.unt.edu/eot2008/20081105151041im_/http://www.ahrq.gov/images/arrow_rt.gif)